Product Images Gvoke Vialdx
View Photos of Packaging, Labels & Appearance
- Its molecular formula is C153H225N43O49S with the following structure: - gvoke vialdx glucagon injection 1
- IFUA-SideB-F2 - gvoke vialdx glucagon injection 10
- IFUA-SideB-F3 - gvoke vialdx glucagon injection 11
- IFUA-SideB-F4 - gvoke vialdx glucagon injection 12
- IFUA-SideB-F5 - gvoke vialdx glucagon injection 13
- IFUA-SideB-F6 - gvoke vialdx glucagon injection 14
- IFUA-SideB-F7 - gvoke vialdx glucagon injection 15
- IFUA-SideB-F8 - gvoke vialdx glucagon injection 16
- IFUA-SideB-F9 - gvoke vialdx glucagon injection 17
- IFUA-SideB-F10 - gvoke vialdx glucagon injection 18
- IFUA-SideB-F11 - gvoke vialdx glucagon injection 19
- Figure 1 - gvoke vialdx glucagon injection 2
- PFS Pouch 1 mg - gvoke vialdx glucagon injection 20
- PFS Image - gvoke vialdx glucagon injection 21
- IFUB SlideB-F1 - gvoke vialdx glucagon injection 22
- IFUB SlideB-F2 - gvoke vialdx glucagon injection 23
- IFUB SlideB-F3 - gvoke vialdx glucagon injection 24
- IFUB SlideB-F4 - gvoke vialdx glucagon injection 25
- IFUB SlideB-F5 - gvoke vialdx glucagon injection 26
- IFUB SlideB-F6 - gvoke vialdx glucagon injection 27
- IFUB SlideB-F7 - gvoke vialdx glucagon injection 28
- IFUB SlideB-F8 - gvoke vialdx glucagon injection 29
- Figure 2 - gvoke vialdx glucagon injection 3
- IFUB SlideB-F9 - gvoke vialdx glucagon injection 30
- IFUB SlideB-F10 - gvoke vialdx glucagon injection 31
- IFUB SlideB-F11 - gvoke vialdx glucagon injection 32
- IFUB SlideB-F12 - gvoke vialdx glucagon injection 33
- Full Vial and Syringe - gvoke vialdx glucagon injection 34
- Gvoke Kit Figure A - gvoke vialdx glucagon injection 35
- Gvoke Kit Figure B - gvoke vialdx glucagon injection 36
- Gvoke Kit Figure C - gvoke vialdx glucagon injection 37
- Gvoke Kit Figure D - gvoke vialdx glucagon injection 38
- Gvoke Kit Figure E - gvoke vialdx glucagon injection 39
- Figure 3 - gvoke vialdx glucagon injection 4
- Gvoke Kit Figure F - gvoke vialdx glucagon injection 40
- Gvoke Kit Figure G - gvoke vialdx glucagon injection 41
- Gvoke Kit Figure H - gvoke vialdx glucagon injection 42
- Gvoke Kit Figure I - gvoke vialdx glucagon injection 43
- Gvoke Kit Figure J - gvoke vialdx glucagon injection 44
- Gvoke Kit Figure K - gvoke vialdx glucagon injection 45
- Gvoke Kit Figure L - gvoke vialdx glucagon injection 46
- Gvoke Kit Figure M - gvoke vialdx glucagon injection 47
- Gvoke Kit Figure N - gvoke vialdx glucagon injection 48
- Gvoke Kit Figure O - gvoke vialdx glucagon injection 49
- Figure 4 - gvoke vialdx glucagon injection 5
- Gvoke Kit Figure P - gvoke vialdx glucagon injection 50
- Gvoke Kit Figure Q - gvoke vialdx glucagon injection 51
- Vial Label - gvoke vialdx glucagon injection 52
- Carton - Single Pack - gvoke vialdx glucagon injection 53
- Carton - 10 Pack - gvoke vialdx glucagon injection 54
- Ai Pouch 1 mg - gvoke vialdx glucagon injection 6
- AI Pouch 0.5 mg - gvoke vialdx glucagon injection 7
- AI Image - gvoke vialdx glucagon injection 8
- IFUA-SideB-F1 - gvoke vialdx glucagon injection 9
Product Label Images
The following 54 images provide visual information about the product associated with Gvoke Vialdx NDC 0517-2901 by American Regent, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Its molecular formula is C153H225N43O49S with the following structure: - gvoke vialdx glucagon injection 1

This appears to be a sequence of amino acids represented by their three-letter codes, ending with the termination codon "COOH". The sequence starts with "NH;", indicating the N-terminus. The sequence consists of 29 amino acids in total.*
IFUA-SideB-F6 - gvoke vialdx glucagon injection 14

This text provides a simple and direct instruction to expose the skin at the injection site. It implies a clear and important step to ensure that the injection is administered correctly and safely.*
IFUA-SideB-F7 - gvoke vialdx glucagon injection 15

This text provides instructions for pushing and holding down a button for 5 seconds.*
IFUA-SideB-F9 - gvoke vialdx glucagon injection 17

This is a description of a medical device, likely a needle guard that can be locked over the needle to prevent accidents or injuries. The text suggests that it allows easy and safe removal from the skin.*
PFS Pouch 1 mg - gvoke vialdx glucagon injection 20

This is a set of instructions for preparing and administering Gvoke PFS (glucagon injection) to treat low blood sugar emergencies. The text details how to tear open the pouch, choose an injection site (lower abdomen, outer thighs, or outer upper arm), pinch the skin, insert the needle at a 90-degree angle, push the plunger down to inject, and call emergency medical help. It also emphasizes not removing air bubbles from the syringe.*
PFS Image - gvoke vialdx glucagon injection 21

Description: This product consists of a NeedleCap, Needle, Finger Flange, Plunger, and a Viewing Window. It is used in conjunction with a Syringe Body for medical or laboratory purposes. The components provide support and functionality for safe and efficient use of the syringe.*
IFUB SlideB-F5 - gvoke vialdx glucagon injection 26

This text indicates a medical instruction to expose the skin at the injection site. This step is commonly done before administering an injection to ensure proper placement and access to the injection site.*
Figure 2 - gvoke vialdx glucagon injection 3

This text provides information on Mean Plasma Glucose (mg/dL) for different age groups. It includes data for ages 2 to under 6 years, ages 6 to under 12 years, and ages 12 to under 18 years. The values are given in milligrams per deciliter (mg/dL). Additionally, the information seems to be related to a time-dependent analysis judging by the mention of "Time (minutes)".*
Full Vial and Syringe - gvoke vialdx glucagon injection 34

This is a description of medical supplies including a Blue Cap, Syringe Needle, Plunger Body, Needle Cap, Vial, and Syringe. It indicates that each Gvoke vial and syringe should be used only once and then discarded for safety reasons.*
Gvoke Kit Figure I - gvoke vialdx glucagon injection 43

This text appears to provide information about dosages for medication. The pediatric dose is 0.1 ml, while the adult dose is 0.2 ml. It seems that the medication is indicated by "TS."*
Gvoke Kit Figure K - gvoke vialdx glucagon injection 45

This text refers to a medical instruction regarding exposing the skin at the injection site, which is a common practice in healthcare settings when administering injections or vaccinations.*
Vial Label - gvoke vialdx glucagon injection 52

This text contains information about a product called Gvoke VialDx™, which has an NDC code of 0517-2901-01. It is indicated for intravenous injection after dilution for diagnostic use only. The product contains 1 mg per 0.2 mL of glucagon injection. It is advised to discard any unused portion of the product. The manufacturer is American Regent located in Shirley, NY 11967. The document contains revision details as RN1220-A Rev.02/2025.*
Carton - Single Pack - gvoke vialdx glucagon injection 53

This text provides important information about a medication called Gvoke VialDx™, which contains a sterile solution for delivery. Each vial contains 0.2 mL and should be stored at a temperature between 15°C to 30°C. The medication should not be refrigerated or exposed to extreme temperatures. Additionally, it mentions the dosage information for intravenous injection after dilution. The text also includes details about the manufacturer, American Regent, Inc., and advice on discarding any unused portions of the vial.*
Ai Pouch 1 mg - gvoke vialdx glucagon injection 6

This text provides instructions for using the Gvoke HypoPen during low blood sugar emergencies. It outlines three main steps: 1. Prepare, 2. Inject, and 3. Assist. The user is instructed to tear open the pouch, choose an injection site, push down on the skin to inject, hold down for 5 seconds, and turn the patient on their side. After the injection, the used pen should be placed in a safe location until it can be disposed of in an FDA-cleared sharps container. The text also references the red cap, needle end, and a window that turns red to indicate when to call for emergency medical help.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.